+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Serum-Free Media Market by Product (BHK Medium, CHO Media, HEK 293 Media), Type (Liquid Media, Semi-solid & Solid Media), End-User, Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 190 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5925132
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Serum-Free Media Market size was estimated at USD 1.52 billion in 2023, USD 1.68 billion in 2024, and is expected to grow at a CAGR of 11.35% to reach USD 3.23 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Serum-Free Media Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Serum-Free Media Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Serum-Free Media Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Co., Inc., ATZ Labz by Life Technologies (India) Pvt Ltd., Becton, Dickinson and Company, Bio-Techne Corporation, Biowest, Celprogen Inc., Corning Incorporated, Danahar Corporation, FUJIFILM Holdings Corporation, Fukoku Co., Ltd., Gmep Incorporated, HiMedia Laboratories., Jimi Biotech, Kyokuto Pharmaceutical Industrial Co., Ltd, Leinco Technologies, Inc., Lonza Group, Merck KgaA, Myoridge Co. Ltd., Nucleus Biologics, PAN-Biotech GmbH, R&D Systems, Inc., REPROCELL Inc., Sartorius AG, Shanghai BioEngine Sci-Tech Co, Ltd, Shanghai Excell Biological Technology Co., Ltd., Sino Biological, Inc., STEMCELL Technologies Canada Inc., Thermo Fisher Scientific Inc., TransGen Biotech Co., Ltd., and ZenBio, Inc.

Market Segmentation & Coverage

This research report categorizes the Serum-Free Media Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • BHK Medium
    • CHO Media
    • HEK 293 Media
    • Stem Cell Medium
    • Vero Medium
  • Type
    • Liquid Media
    • Semi-solid & Solid Media
  • End-User
    • Pharmaceutical & Biotechnology Companies
    • Research & Academic Institutes
  • Application
    • Biopharmaceutical Production
      • Monoclonal Antibodies
      • Vaccines Production
    • Tissue Engineering & Regenerative Medicine
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Serum-Free Media Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Serum-Free Media Market?
  3. What are the technology trends and regulatory frameworks in the Serum-Free Media Market?
  4. What is the market share of the leading vendors in the Serum-Free Media Market?
  5. Which modes and strategic moves are suitable for entering the Serum-Free Media Market?

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Serum-Free Media Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing production of monoclonal antibodies, vaccines, and recombinant proteins
5.1.1.2. Rising government investment and initiatives for stem cell research
5.1.2. Restraints
5.1.2.1. Nutrient limitations and reduced cell proliferation
5.1.3. Opportunities
5.1.3.1. Collaboration among academia and biotech firms to customize serum-free media products
5.1.3.2. Advancements in bioprocess technology and analytical tools
5.1.4. Challenges
5.1.4.1. Complexity of designing and optimizing serum-free media
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Serum-Free Media Market, by Product
6.1. Introduction
6.2. BHK Medium
6.3. CHO Media
6.4. HEK 293 Media
6.5. Stem Cell Medium
6.6. Vero Medium

7. Serum-Free Media Market, by Type
7.1. Introduction
7.2. Liquid Media
7.3. Semi-solid & Solid Media

8. Serum-Free Media Market, by End-User
8.1. Introduction
8.2. Pharmaceutical & Biotechnology Companies
8.3. Research & Academic Institutes

9. Serum-Free Media Market, by Application
9.1. Introduction
9.2. Biopharmaceutical Production
9.3.1. Monoclonal Antibodies
9.3.2. Vaccines Production
9.3. Tissue Engineering & Regenerative Medicine

10. Americas Serum-Free Media Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Serum-Free Media Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Serum-Free Media Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Ajinomoto Co., Inc.
14.1.2. ATZ Labz by Life Technologies (India) Pvt Ltd.
14.1.3. Becton, Dickinson and Company
14.1.4. Bio-Techne Corporation
14.1.5. Biowest
14.1.6. Celprogen Inc.
14.1.7. Corning Incorporated
14.1.8. Danahar Corporation
14.1.9. FUJIFILM Holdings Corporation
14.1.10. Fukoku Co., Ltd.
14.1.11. Gmep Incorporated
14.1.12. HiMedia Laboratories.
14.1.13. Jimi Biotech
14.1.14. Kyokuto Pharmaceutical Industrial Co., Ltd
14.1.15. Leinco Technologies, Inc.
14.1.16. Lonza Group
14.1.17. Merck KgaA
14.1.18. Myoridge Co. Ltd.
14.1.19. Nucleus Biologics
14.1.20. PAN-Biotech GmbH
14.1.21. R&D Systems, Inc.
14.1.22. REPROCELL Inc.
14.1.23. Sartorius AG
14.1.24. Shanghai BioEngine Sci-Tech Co, Ltd
14.1.25. Shanghai Excell Biological Technology Co., Ltd.
14.1.26. Sino Biological, Inc.
14.1.27. STEMCELL Technologies Canada Inc.
14.1.28. Thermo Fisher Scientific Inc.
14.1.29. TransGen Biotech Co., Ltd.
14.1.30. ZenBio, Inc.
14.2. Key Product Portfolio

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

List of Figures
FIGURE 1. SERUM-FREE MEDIA MARKET RESEARCH PROCESS
FIGURE 2. SERUM-FREE MEDIA MARKET SIZE, 2023 VS 2030
FIGURE 3. SERUM-FREE MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. SERUM-FREE MEDIA MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. SERUM-FREE MEDIA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. SERUM-FREE MEDIA MARKET DYNAMICS
FIGURE 7. SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 10. SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. SERUM-FREE MEDIA MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. SERUM-FREE MEDIA MARKET SHARE, BY KEY PLAYER, 2023


List of Tables
TABLE 1. SERUM-FREE MEDIA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. SERUM-FREE MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. SERUM-FREE MEDIA MARKET SIZE, BY BHK MEDIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. SERUM-FREE MEDIA MARKET SIZE, BY CHO MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. SERUM-FREE MEDIA MARKET SIZE, BY HEK 293 MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. SERUM-FREE MEDIA MARKET SIZE, BY STEM CELL MEDIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. SERUM-FREE MEDIA MARKET SIZE, BY VERO MEDIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 12. SERUM-FREE MEDIA MARKET SIZE, BY LIQUID MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. SERUM-FREE MEDIA MARKET SIZE, BY SEMI-SOLID & SOLID MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 15. SERUM-FREE MEDIA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. SERUM-FREE MEDIA MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 20. SERUM-FREE MEDIA MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. SERUM-FREE MEDIA MARKET SIZE, BY VACCINES PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. SERUM-FREE MEDIA MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 39. CANADA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. CANADA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. CANADA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. CANADA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. CANADA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 44. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. MEXICO SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES SERUM-FREE MEDIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 61. AUSTRALIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 66. CHINA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. CHINA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. CHINA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. CHINA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. CHINA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 71. INDIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. INDIA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. INDIA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. INDIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. INDIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 76. INDONESIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 81. JAPAN SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. JAPAN SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. JAPAN SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. JAPAN SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. JAPAN SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 86. MALAYSIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. MALAYSIA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 91. PHILIPPINES SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. PHILIPPINES SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 96. SINGAPORE SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. SINGAPORE SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 101. SOUTH KOREA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. SOUTH KOREA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 106. TAIWAN SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. TAIWAN SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 111. THAILAND SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. THAILAND SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. THAILAND SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. THAILAND SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. THAILAND SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 116. VIETNAM SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. VIETNAM SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 127. DENMARK SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. DENMARK SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. DENMARK SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. DENMARK SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. DENMARK SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 132. EGYPT SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. EGYPT SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. EGYPT SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. EGYPT SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. EGYPT SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 137. FINLAND SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. FINLAND SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. FINLAND SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. FINLAND SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. FINLAND SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 142. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. FRANCE SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 147. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. GERMANY SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 152. ISRAEL SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 157. ITALY SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. ITALY SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 159. ITALY SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. ITALY SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. ITALY SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 167. NIGERIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. NIGERIA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 172. NORWAY SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. NORWAY SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 174. NORWAY SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. NORWAY SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. NORWAY SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 177. POLAND SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. POLAND SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 179. POLAND SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. POLAND SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. POLAND SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 182. QATAR SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. QATAR SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 184. QATAR SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. QATAR SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. QATAR SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 202. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 203. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 204. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 205. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. SPAIN SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 212. SWITZERLAND SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 213. SWITZERLAND SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 217. TURKEY SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 218. TURKEY SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 219. TURKEY SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 220. TURKEY SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. TURKEY SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM SERUM-FREE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
TABLE 232. SERUM-FREE MEDIA MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 233. SERUM-FREE MEDIA MARKET SHARE, BY KEY PLAYER, 2023
TABLE 234. SERUM-FREE MEDIA MARKET LICENSE & PRICING

Companies Mentioned

  • Ajinomoto Co., Inc.
  • ATZ Labz by Life Technologies (India) Pvt Ltd.
  • Becton, Dickinson and Company
  • Bio-Techne Corporation
  • Biowest
  • Celprogen Inc.
  • Corning Incorporated
  • Danahar Corporation
  • FUJIFILM Holdings Corporation
  • Fukoku Co., Ltd.
  • Gmep Incorporated
  • HiMedia Laboratories.
  • Jimi Biotech
  • Kyokuto Pharmaceutical Industrial Co., Ltd
  • Leinco Technologies, Inc.
  • Lonza Group
  • Merck KgaA
  • Myoridge Co. Ltd.
  • Nucleus Biologics
  • PAN-Biotech GmbH
  • R&D Systems, Inc.
  • REPROCELL Inc.
  • Sartorius AG
  • Shanghai BioEngine Sci-Tech Co, Ltd
  • Shanghai Excell Biological Technology Co., Ltd.
  • Sino Biological, Inc.
  • STEMCELL Technologies Canada Inc.
  • Thermo Fisher Scientific Inc.
  • TransGen Biotech Co., Ltd.
  • ZenBio, Inc.

Methodology

Loading
LOADING...

Table Information